While cancers such as breast, lung, and prostate frequently dominate public health discussions, there is a far less recognised but equally aggressive form - sarcoma. It affects thousands across the UK ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...

Shame can shape how early patients get diagnosed, and how aggressively they pursue treatment, if at all. In a 2014 study, Dr.

Highlighting the urgent need for awareness and support for sarcoma, a rarely discussed but serious cancer affecting many.

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Moleculin Biotech, Inc. announced promising results from their Phase 1B/2 trial of Annamycin for treating soft tissue sarcoma lung metastases, showing a robust clinical benefit rate of 59.4% among ...

With the rising burden of cancer in India, awareness around common cancers such as breast, lung and oral cancer has increased ...

I am a two-time cancer survivor. In 2016, I was diagnosed with synovial sarcoma and completed my treatment in 2017. Later, in ...

Every July, Sarcoma Awareness Month reminds us of a cancer that’s often sidelined in public discourse. However, sarcoma is not just one disease, it is a group of rare cancers with over 150 subtypes, ...

A small subpopulation of highly plastic cancer cells has been found to be for cancer progression and treatment resistance.